BCC (Basal Cell Carcinoma),SCC (Squamous Cell Carcinoma),Skin Cancer Intralesional T-VEC Induces Clinical Responses and Activates Immune Response in CBCL Lesions Aug 14, 2023
Melanoma,Skin Cancer Phase 3 Trial: Fianlimab + Cemiplimab vs. Pembrolizumab in High-Risk Melanoma Jul 31, 2023
Melanoma,Skin Cancer 1L Atezolizumab With Vemurafenib and Cobimetinib Improves OS in BRAFV600 Advanced Melanoma Jun 01, 2023
Melanoma,Skin Cancer NNT and NNH Utilized to Assess the Efficacy and Safety of Adjuvant Therapies in Melanoma Jun 01, 2023
Melanoma,Skin Cancer Tumor Biomarker Analysis of Encorafenib + Binimetinib in Advanced Melanoma Jun 01, 2023
Melanoma,Skin Cancer Before or After: The Debate on Pembrolizumab Administration for High-Risk Melanoma Jun 01, 2023
Melanoma,Skin Cancer Adjuvant Pembrolizumab or Placebo in Stage III Melanoma: 5-Year Analysis May 22, 2023
